Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Gabriela Zamora-Ortiz"'
1
Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction
Autor: Sara Velázquez-Sánchez-de-Cima, Guillermo J. Ruiz-Argüelles, Gabriela Zamora-Ortiz, Guillermo J. Ruiz-Delgado, Sergio Ponce-de-León, César Homero Gutiérrez-Aguirre, David Gómez-Almaguer
Publikováno v: Hematology. 19:435-440
Patients given allogeneic hematopoietic stem cell transplants (HSCT) may develop secondary malignant neoplasms (SMN). Several variables have been identified but there are no data about the incidence of this complication in individuals given HSCT usin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1be6a8262f7dee101b78871b936acb7
https://doi.org/10.1179/1607845414y.0000000154
Zobrazit plný text záznamu
2
Oral versus Intravenous Fludarabine as Part of a Reduced-Intensity Conditioning for Allogeneic Stem Cell Transplantation
Autor: Monica P. Gonzalez-Ramirez, Sara Velázquez-Sánchez-de-Cima, Guillermo J. Ruiz-Delgado, Jesús Hernández-Reyes, Guillermo J. Ruiz-Argüelles, Gabriela Zamora-Ortiz, Alan Daniel Rosales-Durón, Nora Angela Martagón-Herrera
Publikováno v: Acta Haematologica. 132:125-128
Background: In 2003, oral fludarabine was introduced in the USA for the treatment of patients with hematologic malignancies as an alternative to its intravenous (i.v.) formulation; in 2008, it was introduced in México while the i.v. formulation was
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f6c6981cdc9413ac0b09dcf8b358e776
https://doi.org/10.1159/000357108
Zobrazit plný text záznamu
3
Primary Thrombophilia in México X
Autor: Sara Velázquez-Sánchez-de-Cima, Gabriela Zamora-Ortiz, Alejandro Ruiz-Argüelles, Guillermo J. Ruiz-Argüelles, Jaime Rosales-Padrón, Jocelyn Vargas-Espinosa, Jessica García-Chavez, Jesús Hernández-Reyes, Guillermo J. Ruiz-Delgado
Publikováno v: Clinical and Applied Thrombosis/Hemostasis. 21:91-95
Introduction: The sticky platelet syndrome (SPS) is a common cause of thrombosis. There are no prospective studies concerning treatment. Objective: To analyze changes in platelet hyperaggregability of patients with SPS who were given antiplatelet dru
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86682b82fc3e722aa8279c62bc9ba420
https://doi.org/10.1177/1076029613501543
Zobrazit plný text záznamu
4
In pursuit of the graft-versus-myeloma effect: A single institution experience
Autor: Evelyn Galo-Hooker, Gabriela Zamora-Ortiz, Sara Velázquez-Sánchez-de-Cima, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles
Publikováno v: Hematology. 18:89-92
Partly because of a potential graft-versus-myeloma effect, allogeneic stem cell transplantation is a potentially curative treatment modality in patients with multiple myeloma (MM). Initial attempts have been hampered by the high transplant-related mo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea908a1a1f73c5ecf863388ba16b628b
https://doi.org/10.1179/1607845412y.0000000041
Zobrazit plný text záznamu
5
Poor performance of the total kappa/lambda light chain quantification in the diagnosis and follow-up of patients with multiple myeloma
Autor: Gabriela, Zamora-Ortiz, Sara, Velázquez-Sánchez-de-Cima, Jesus, Hernández-Reyes, Nora Angela, Martagón-Herrera, Alejandro, Ruiz-Argüelles, Guillermo J, Ruiz-Delgado, Guillermo J, Ruiz-Argüelles
Publikováno v: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 66(4)
The gold standard for paraproteinemia screening in plasma cell disorders has been serum protein electro- phoresis (SPE) with immunofixation electrophoresis (IFx); serum total and free light chain quantifications have also been used.To define the role
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::144003b7b7f6c920092936f58e67f115
https://pubmed.ncbi.nlm.nih.gov/25695391
Zobrazit plný text záznamu
6
Nonalcoholic fatty liver disease may cause thrombocytopenia
Autor: Gabriela Zamora-Ortiz, Guillermo J. Ruiz-Delgado, Jesús Hernández-Reyes, Guillermo J. Ruiz-Argüelles, Sara Velázquez-Sánchez-de-Cima
Publikováno v: Acta haematologica. 132(2)
/l) were prospectively studied. Pa-tients with immune thrombocytopenia [7] , overt viral hepatitis or liver cirrhosis were excluded. The study was approved by the Ethics Committee of the Clinica Ruiz and informed consent was obtained from the patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bde6e6b930644ab85e42239d40790d19
https://pubmed.ncbi.nlm.nih.gov/24577377
Zobrazit plný text záznamu
7
Oral versus intravenous fludarabine as part of a reduced-intensity conditioning for allogeneic stem cell transplantation
Autor: Sara, Velázquez-Sánchez-de-Cima, Gabriela, Zamora-Ortiz, Jesús, Hernández-Reyes, Alan Daniel, Rosales-Durón, Mónica Patricia, González-Ramírez, Nora Angela, Martagón-Herrera, Guillermo J, Ruiz-Delgado, Guillermo J, Ruiz-Argüelles
Publikováno v: Acta haematologica. 132(1)
In 2003, oral fludarabine was introduced in the USA for the treatment of patients with hematologic malignancies as an alternative to its intravenous (i.v.) formulation; in 2008, it was introduced in México while the i.v. formulation was withdrawn. A
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0c936331e04173c321e3ae87d6b8d059
https://pubmed.ncbi.nlm.nih.gov/24556580
Zobrazit plný text záznamu
8
Diagnosing and treating mixed phenotype acute leukemia: a multicenter 10-year experience in México
Autor: Martha Alvarado-Ibarra, Marcela Deffis-Court, Xavier López-Karpovitch, Alvaro Aguayo-González, Manuel López-Hernández, Georgina Barrera-Lumbreras, Guillermo J. Ruiz-Argüelles, Adriana Rosas-López, Gabriela Zamora-Ortiz, Sara Velázquez-Sánchez de Cima, Erick Crespo-Solís
Publikováno v: Annals of hematology. 93(4)
Mixed phenotype acute leukemia (MPAL) in adults represents nearly 2 to 5 % of all acute leukemia cases. There are two large studies throughout the world and only case reports and small series have been reported in Latin America. This study retrospect
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb5358744b84bfbe48d883cd6a8db23
https://pubmed.ncbi.nlm.nih.gov/24146232
Zobrazit plný text záznamu
10
Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab
Autor: Guillermo J. Ruiz-Argüelles, Sara Velázquez-Sánchez-de-Cima, Guillermo J. Ruiz-Delgado, Gabriela Zamora-Ortiz
Publikováno v: Hematology (Amsterdam, Netherlands). 18(3)
A 58-year-old woman presented with rheumatoid arthritis-associated Evans syndrome (simultaneous autoimmune hemolytic anemia and autoimmune thrombocytopenic purpura); she was treated unsuccessfully with steroids, romiplostin, rituximab, immunoglobulin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ba1578c0804cc12e81e89080215d4d
https://pubmed.ncbi.nlm.nih.gov/23321502
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje